Figure 8. Immune status analysis between high- and low-risk group. (A) The ssGSEA scores of immune cells. (B) The ssGSEA scores of immune-related functions. (C–E) Comparisons of Estimated, immune and stromal score between high-and low-risk group. (F–K) Correlation between risk score and immune markers (Macrophages M0, Monocytes, NK cells activated, Macrophages M1, M2, and Mast cells activated) in glioma patients.